Unknown PHASE1 INTERVENTIONAL 3-arm NCT02294448

PopPK Profile of Qishe Pill: Study Protocol for a Phase I Clinical Trial

Population Pharmacokinetic Modeling of Qishe Pill in Three Major TCM-defined Constitutional Types of Healthy Chinese Subjects: Study Protocol for a Phase I Clinical Trial

Sponsor: Shanghai University of Traditional Chinese Medicine

Conditions Individuality Narrative Medicine

Interventions Qishe Pill

Updated 6 times since 2017 Last updated: Nov 15, 2014 Started: Nov 30, 2014 Primary completion: Dec 31, 2015 Completion: Jul 31, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE1 trial investigates Individuality and Narrative Medicine and is currently ongoing. Shanghai University of Traditional Chinese Medicine leads this study, which shows 6 recorded versions since 2014 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Unknown PHASE1
Sep 2024 — Sep 2025 [monthly]

Unknown PHASE1
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE1

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE1
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE1

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Unknown Status PHASE1

First recorded

Nov 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Shanghai University of Traditional Chinese Medicine

Data source: Shanghai University of Traditional Chinese Medicine

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Shanghai, China